Stigmabase | HIV

Antiretroviral therapy can hold HIV in check for a lifetime, but it cannot clear it. A small number of infected cells carry a complete, ... View article...

The twice-yearly HIV prevention injection is being rolled out at select clinics in SA. View article...

From counselling about small nodules to overcoming people's fears of needles, Biénne Huisman takes the pulse of a new HIV prevention injection's ... View article...

FDA approved Bixlenvo, a once-daily tablet combining bictegravir and lenacapavir for virologically suppressed adults on complex HIV regimens. View article...

Sub-Saharan Africa remains hardest hit as millions of children live with HIV or lose parents, facing heightened risks of poverty, stigma and lost ... View article...

The FDA has approved Bixlenvo, a new combination drug from Gilead Sciences, for treating HIV in adults. The drug is for people with suppressed ... View article...

The planned cuts - targeting programs that combat the spread of HIV /AIDS, Ebola and tuberculosis, among other deadly diseases - appear to reduce U.S. ... View article...

South Africa has the largest HIV epidemic globally. Despite improvement, retention on antiretroviral therapy (ART) remains challenging. View article...